ADIL Azora Therapeutics, Inc. (DE)
Fundamentals / CIK 0001513525 / USDAzora Therapeutics, Inc. (DE) reported $22.53M in total assets and a net loss of $120.6M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ADIL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$63.44M Operating profit
-
Net Income FY 2025-$120.6M GAAP bottom line
-
Diluted EPS FY 2025-$8.43 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$22.00M Total debt: --
Annual revenue and net income
9 fiscal years (2017 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Research & Development | $2.62M | $3.23M | $1.27M | $1.95M | $8.40M | $5.85M | $3.97M | $368K | $182K |
| Total Operating Expenses | $7.80M | $8.28M | $6.89M | $10.86M | $19.29M | $10.93M | $8.24M | $6.99M | $995K |
| Operating Income | -$7.80M | -$8.28M | -$6.89M | -$10.86M | -$19.29M | -$10.93M | -$8.24M | -$6.99M | -$995K |
| Interest Income | $150K | $179K | $70K | $63K | $6.5K | $32K | $95K | $7.4K | $367 |
| Income Before Tax | -$7.98M | -$13.20M | -$7.00M | -$10.80M | -$19.52M | -$10.89M | -$8.59M | -$11.63M | -$1.14M |
| Income Tax Expense | -- | -- | -- | -$502 | -$94K | -- | -- | -- | -- |
| Net Income | -$7.98M | -$13.20M | -$5.12M | -$12.73M | -$19.42M | -$10.89M | -$8.59M | -$11.63M | -$1.14M |
| Basic EPS | -$11.93 | -$68.01 | -$90.00 | -$317.75 | -$650.00 | -$543.75 | -$543.75 | -$1,525.00 | -$218.75 |
| Diluted EPS | -$11.93 | -$68.01 | -$90.00 | -$317.75 | -$650.00 | -$543.75 | -$543.75 | -$1,525.00 | -$218.75 |
| Basic Shares Outstanding | 668.6K | 194.1K | -- | 40.1K | 29.7K | 19.9K | 15.8K | 7.6K | 5.2K |
| Diluted Shares Outstanding | 668.6K | 194.1K | 57.0K | 40.1K | 29.7K | 19.9K | 15.8K | 389 | 279 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $1.77M | $440K | $433K | $620K | $521K | $732K | $747K | $731K |
| Total Operating Expenses | $7.53M | $52.02M | $2.00M | $1.89M | $1.76M | $1.88M | $2.27M | $1.94M |
| Operating Income | -$7.53M | -$52.02M | -$2.00M | -$1.89M | -$1.76M | -$1.88M | -$2.27M | -$1.94M |
| Interest Income | $170K | $58K | $47K | $43K | $48K | $24K | $35K | $54K |
| Net Income | -$64.56M | -$51.99M | -$2.02M | -$2.00M | -$1.79M | -$1.96M | -$2.23M | -$2.07M |
| Basic EPS | -$4.52 | -$11.25 | -$1.48 | -- | -$2.02 | -$4.61 | -$8.52 | -- |
| Diluted EPS | -$4.52 | -$11.25 | -$1.48 | -- | -$2.02 | -$4.61 | -$8.52 | -- |
| Basic Shares Outstanding | 14.3M | 4.6M | 1.4M | -- | 886.9K | 424.9K | 261.6K | -- |
| Diluted Shares Outstanding | 14.3M | 4.6M | 1.4M | -- | 886.9K | 424.9K | 261.6K | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $5.88M | $3.75M | $2.83M | $4.00M | $6.06M | $4.40M | $6.78M | $3.87M | $18K |
| Cash & Short-Term Investments | $5.88M | $3.75M | $2.83M | $4.00M | $6.06M | $4.40M | $6.78M | $3.87M | $18K |
| Total Current Assets | $6.18M | $4.06M | $3.20M | $4.78M | $6.46M | $5.14M | $7.67M | $4.69M | $27K |
| Property, Plant & Equipment, Net | -- | -- | -- | $50K | $58K | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | $249K | $249K | -- | -- | -- | -- |
| Intangible Assets | $3.0K | $3.3K | $3.9K | $4.5K | $5.0K | $5.6K | $6.2K | $6.7K | $7.3K |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | $6.2K | $6.7K | $7.3K |
| Total Non-Current Assets | $493K | $985K | $1.54M | $953K | $1.01M | $356K | $6.2K | $6.7K | $7.3K |
| Total Assets | $6.67M | $5.04M | $4.74M | $5.73M | $7.47M | $5.49M | $7.68M | $4.70M | $35K |
| Accounts Payable | $655K | $250K | $103K | $276K | $286K | $649K | $190K | $100K | -- |
| Other Current Liabilities | -- | -- | -- | $10K | $9.7K | -- | -- | -- | -- |
| Total Current Liabilities | $1.40M | $976K | $653K | $1.79M | $2.72M | $1.51M | $539K | $258K | $1.03M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $665K | $1.24M | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.40M | $976K | $653K | $2.46M | $3.97M | $1.51M | $539K | $258K | $1.03M |
| Total Debt (incl. Leases) | -- | -- | -- | $207K | $464K | -- | -- | -- | -- |
| Common Stock | $1.0K | $259 | $1.7K | $1.1K | $21K | $14K | $10K | $6.9K | $3.3K |
| Retained Earnings | -$89.97M | -$82.00M | -$68.80M | -$63.67M | -$50.94M | -$31.52M | -$20.63M | -$12.04M | -$404K |
| Total Stockholders' Equity | $5.28M | $4.07M | $4.08M | $3.28M | $3.51M | $3.99M | $7.14M | $4.44M | -$998K |
| Total Equity | $5.28M | $4.07M | $4.08M | $3.28M | $3.51M | $3.99M | $7.14M | $4.44M | -$998K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $22.00M | -- | -- | $5.88M | $4.61M | $5.91M | $2.37M | $3.75M |
| Cash & Short-Term Investments | $22.00M | -- | -- | $5.88M | $4.61M | $5.91M | $2.37M | $3.75M |
| Total Current Assets | $22.38M | $28.84M | $4.80M | $6.18M | $5.01M | $6.08M | $2.63M | $4.06M |
| Intangible Assets | $3.0K | $3.0K | $2.6K | $3.0K | $2.9K | $3.1K | $3.2K | $3.3K |
| Total Non-Current Assets | $151K | $244K | $424K | $493K | $646K | $723K | $822K | $985K |
| Total Assets | $22.53M | $29.09M | $5.23M | $6.67M | $5.66M | $6.80M | $3.45M | $5.04M |
| Accounts Payable | $1.39M | $2.62M | $574K | $655K | $556K | $671K | $532K | $250K |
| Total Current Liabilities | $5.06M | $5.12M | $1.51M | $1.40M | $1.15M | $1.21M | $1.32M | $976K |
| Total Non-Current Liabilities | $0 | $23.81M | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $5.06M | $28.93M | $1.51M | $1.40M | $1.15M | $1.21M | $1.32M | $976K |
| Common Stock | $3.0K | $3.0K | $1.5K | $1.0K | $24K | $22K | $6.7K | $259 |
| Retained Earnings | -$208.5M | -$144.0M | -$91.99M | -$89.97M | -$87.98M | -$86.18M | -$84.22M | -$82.00M |
| Total Stockholders' Equity | -$21.06M | -$38.38M | $3.72M | $5.28M | $4.50M | $5.59M | $2.13M | $4.07M |
| Total Equity | -$21.06M | -$38.38M | $3.72M | $5.28M | $4.50M | $5.59M | $2.13M | $4.07M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$7.98M | -$13.20M | -$5.12M | -$12.73M | -$19.42M | -$10.89M | -$8.59M | -$11.63M | -$1.14M |
| Stock-Based Compensation | $676K | $797K | $1.75M | $3.37M | $4.24M | $2.01M | $1.60M | $5.37M | $205K |
| Change in Payables | -- | -- | -$183K | $16K | -$354K | $625K | $91K | -- | -- |
| Operating Cash Flow | -$6.49M | -$6.92M | -$6.81M | -$11.19M | -$11.95M | -$7.63M | -$6.34M | -$2.50M | -$495K |
| Capital Expenditure | -- | -- | -- | -- | -$65K | -- | -- | -- | -- |
| Free Cash Flow | -- | -- | -- | -- | -$12.01M | -- | -- | -- | -- |
| Acquisitions, Net | -- | -- | -- | -- | $31K | -- | -- | -- | -- |
| Investing Cash Flow | $150K | -- | $1.50M | -- | -$34K | -$350K | -- | -- | $35K |
| Common Stock Issued | $3.66M | $4.02M | $750K | $9.12M | $11.75M | $5.16M | $8.20M | $6.27M | $40K |
| Share Repurchases | -- | -- | -$1.7K | -- | -- | -- | -- | -- | -- |
| Financing Cash Flow | $8.47M | $7.85M | $4.13M | $9.13M | $13.64M | $5.61M | $9.25M | $6.35M | $390K |
| Net Change in Cash | $2.13M | $923K | -$1.17M | -$2.06M | $1.66M | -$2.38M | $2.91M | $3.85M | -$70K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$64.56M | -$51.99M | -$2.02M | -$2.00M | -$1.79M | -$1.96M | -$2.23M | -$2.07M |
| Stock-Based Compensation | $958K | $137K | $148K | $168K | $147K | $124K | $237K | $180K |
| Change in Payables | -$1.20M | $1.74M | -$82K | -- | -$113K | $138K | $282K | -- |
| Operating Cash Flow | -$6.63M | -$6.36M | -$1.61M | -$1.32M | -$1.83M | -$1.75M | -$1.59M | -$1.45M |
| Investing Cash Flow | -- | -- | -- | $0 | $0 | $0 | $150K | -- |
| Common Stock Issued | $0 | $850K | $315K | $54K | $478K | $3.08M | $51K | -- |
| Financing Cash Flow | -$35K | $25.21M | $315K | $2.60M | $525K | $5.30M | $51K | $0 |
| Net Change in Cash | -$6.67M | $24.13M | -$1.30M | $1.27M | -$1.31M | $3.55M | -$1.38M | -$1.45M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -151.2% | -324.4% | -125.5% | -388.6% | -553.7% | -273.3% | -120.3% | -261.9% | -- |
| Return on Assets (ROA) | -119.5% | -261.6% | -108.2% | -222.1% | -259.8% | -198.4% | -111.9% | -247.5% | -3298.4% |
| Current Ratio | 4.42x | 4.16x | 4.90x | 2.67x | 2.37x | 3.41x | 14.24x | 18.19x | 0.03x |
| Quick Ratio | 4.21x | 3.84x | 4.33x | 2.23x | 2.23x | 2.92x | 12.57x | 15.00x | 0.02x |
| Debt to Equity | -- | -- | -- | 0.06x | 0.13x | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -- | -209.1% | -151.2% | -178.7% | -151.2% | -421.0% | -324.4% |
| Return on Assets (ROA) | -535.2% | -198.7% | -148.7% | -119.5% | -142.3% | -124.2% | -259.3% | -261.6% |
| Current Ratio | 4.43x | 5.63x | 3.18x | 4.42x | 4.34x | 5.02x | 1.99x | 4.16x |
| Quick Ratio | 4.35x | -- | -- | 4.21x | 3.99x | 4.88x | 1.79x | 3.84x |